{"id":"apstzd-1","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Further research is needed to determine the exact mechanism of action of APSTZD 1.","oneSentence":"APSTZD 1 is an investigational drug with unknown mechanism of action.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T02:28:58.977Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07420816","phase":"PHASE2","title":"Efficacy and Safety of APSTZD in the Treatment of Insomnia Disorder","status":"NOT_YET_RECRUITING","sponsor":"Apsen Farmaceutica S.A.","startDate":"2026-03-26","conditions":"Insomnia, Insomnia Chronic","enrollment":222}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":10168283,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"APSTZD 1","genericName":"APSTZD 1","companyName":"Apsen Farmaceutica S.A.","companyId":"apsen-farmaceutica-s-a","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}